Yi Wan

机构：Affiliated Zhongshan Hospital of Dalian University, Air Force Medical University · ORCID：0000-0001-5549-0375

发表论文 31 篇 · 总被引 133 次 · h-index 8

代表论文

• Semaphorins as Potential Immune Therapeutic Targets for Cancer (2022 · Frontiers in Oncology · 被引 20)
• Functional heterogeneity of cancer-associated fibroblasts with distinct neoadjuvant immunotherapy plus chemotherapy response in esophageal squamous cell carcinoma (2024 · Biomarker Research · 被引 16)
• TMEM16 and OSCA/TMEM63 proteins share a conserved potential to permeate ions and phospholipids (2024 · eLife · 被引 14)
• Comprehensive analysis of pyroptosis regulation patterns and their influence on tumor immune microenvironment and patient prognosis in glioma (2022 · Discover Oncology · 被引 11)
• Nitric oxide inhibits alginate biosynthesis in Pseudomonas aeruginosa and increases its sensitivity to tobramycin by downregulating algU gene expression (2022 · Nitric Oxide · 被引 10)
• Clinical characteristics of second primary malignancies among first primary malignancy survivors: A single‑center study, 2005‑2020 (2022 · Oncology Letters · 被引 9)